跳至主要内容
临床试验/CTRI/2018/11/016296
CTRI/2018/11/016296尚未招募未知

Translation of CpG-Methylation Biosignatures of Genes for Rapid and Sensitive Diagnostic and Prognostic Applications during Cervical Cancer Progression

Dr K Satyamoorthy0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Case: Women aged between 21-65 years with pre-malignant and malignant cervical lesions are included in this study.
  • Control: Women aged between 21-65 years without any cervical lesions or symptoms are included as control participants.

排除标准

  • Case: Women who are pregnant or lactating; who have undergone hysterectomy; who are diagnosed and have already started treatment for cervical lesions and malignancies are excluded from the study.
  • Control: Women who are pregnant or lactating; who have undergone hysterectomy; who are diagnosed and have already started treatment for cervical lesions and malignancies are excluded from the study.

研究者

发起方
Dr K Satyamoorthy

相似试验